1. Home
  2. STWD vs PCVX Comparison

STWD vs PCVX Comparison

Compare STWD & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

HOLD

Current Price

$16.02

Market Cap

6.2B

Sector

Real Estate

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$54.08

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STWD
PCVX
Founded
2009
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
7.0B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
STWD
PCVX
Price
$16.02
$54.08
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$20.00
$88.25
AVG Volume (30 Days)
3.4M
991.2K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
10.64%
N/A
EPS Growth
4.55
N/A
EPS
0.13
N/A
Revenue
$1,844,289,000.00
N/A
Revenue This Year
$283.44
N/A
Revenue Next Year
$17.66
N/A
P/E Ratio
$124.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.11
$29.10
52 Week High
$20.84
$65.00

Technical Indicators

Market Signals
Indicator
STWD
PCVX
Relative Strength Index (RSI) 36.61 46.81
Support Level N/A $52.04
Resistance Level $18.54 $56.04
Average True Range (ATR) 0.27 2.38
MACD -0.03 -0.48
Stochastic Oscillator 7.97 25.98

Price Performance

Historical Comparison
STWD
PCVX

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: